Texas Tech University Health Sciences Center
Texas Tech University Health Sciences Center
Lubbock, Texas, United States20 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors | Disease Attributes, Ewing sarcoma, Myosarcoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, connective tissue neoplasm, epithelial neoplasm, myomatous neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, osteosarcoma, primitive neuroectodermal tumor, rhabdomyosarcoma, sarcoma | Recruiting | Phase 1 | 2026-10-08 | NCT02013336 | |
| Tocotrienols for Obesity of Postmenopausal Women | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-02 | NCT03705845 | |
| CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemorrhage, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Hemorrhagic, Urogenital Diseases, diabetes insipidus, endocrine system disorder, injury, kidney disorder, pituitary gland disorder, urinary system disorder | Recruiting | Phase 2 | 2026-09-29 | NCT05958342 | |
| Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease | Proteinuric Kidney Disease | Recruiting | Phase 2 / Phase 3 | 2026-09-21 | NCT05312879 | |
| Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature | cardiovascular disorder, peripheral vascular disease, vascular disorder | Recruiting | Not stated | 2026-09-15 | NCT04674969 | |
| Annatto-derived GG for Statin-associated Myopathy | muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Recruiting | Phase 1 / Phase 2 | 2026-09-11 | NCT05312424 | |
| Snacks and Brain Health | Inflammation, Neuroinflammatory Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, nervous system disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-08 | NCT07348406 | |
| OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, coronary artery disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Phase 3 | 2026-08-21 | NCT07136012 | |
| CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Not applicable | 2026-08-11 | NCT06601166 | |
| Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy | Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Recruiting | Early phase 1 | 2026-07-08 | NCT06349772 | |
| Stroboscopic Vision Training in Softball | Sports Performance; Vision, Ocular | Active, not recruiting | Not applicable | 2026-06-29 | NCT04309188 | |
| Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, injury, radiation injury | Recruiting | Phase 1 / Phase 2 | 2026-06-29 | NCT03934905 | |
| Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitation Following Ankle Ligament Reconstruction | Ankle Reconstruction; Blood Flow Restriction Therapy; Physical Therapy | Recruiting | Not applicable | 2026-03-17 | NCT07451210 | |
| Persona Total Knee Arthroplasty Outcomes Study | Genu Valgum, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, polyarticular arthritis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not applicable | 2026-03-10 | NCT02255383 | |
| Speech Intervention Via Telepractice for Children With Repaired Cleft Palate | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, Jaw Abnormalities, Jaw Diseases, Maxillofacial Abnormalities, Mouth Abnormalities, Musculoskeletal Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Speech Sound Disorder, Stomatognathic Diseases, Stomatognathic System Abnormalities, cleft palate, communication disorder, mouth disorder, musculoskeletal system disorder, nervous system disorder, neurodevelopmental disorder, psychiatric disorder | Not yet recruiting | Not applicable | 2026-02-27 | NCT07434375 | |
| Curcumin and Retinal Study | Bioavailability; Gut Microbiome; Safety | Recruiting | Phase 1 / Phase 2 | 2026-01-13 | NCT05774704 | |
| Ginger Root Extract for Sciatic Pain Individuals | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder | Recruiting | Phase 2 | 2025-12-30 | NCT06817018 | |
| SELUTION SLR™ 014 In-stent Restenosis | cardiovascular disorder, coronary artery disorder, coronary restenosis, coronary stenosis, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2025-12-17 | NCT04280029 | |
| Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, drug allergy | Recruiting | Phase 3 | 2025-05-01 | NCT06303128 | |
| RADIANCE Continued Access Protocol | Hypertension Resistant to Conventional Therapy, cardiovascular disorder, essential hypertension, hypertensive disorder, vascular disorder | Active, not recruiting | Not applicable | 2024-06-17 | NCT05017935 |